Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


RCUK (Research Councils UK) prepares to allocate £2.9billion science budget:

This article was originally published in Clinica

Executive Summary

Research Councils UK has welcomed the government's pledge to increase the science budget to £2.9bn ($4.6bn) by 2005-06, as it prepares to discuss how the funding should be allocated. The budget (see Clinica No 1016, p 7) includes a £300m contribution to the £500m per annum capital fund for research infrastructure; additional funding is to be allocated to establishing large research facilities. Launched in May 2002, the RCUK comprises seven research councils, including the Medical Research Council, the Biotechnology and Biological Sciences Research Council and the Council for the Central Laboratory of the Research Councils. The RCUK is due to publish details of the budget allocation in November.

You may also be interested in...

Orphan Indications In Medicare: Inspector General Will Examine Top-Selling Drugs

OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.


ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts